Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the Elderly
Clinical trial NCT00938392 · COMPLETED
Trial details
- NCT number
- NCT00938392
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-30
- Primary completion
- 2009-10-05
- Enrollment
- 726
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.